PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB決算レポート
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
PACB Q4 2025 Key Financial Metrics
売上高
$44.6M
粗利益
$16.6M
営業利益
$-41.2M
純利益
$-40.4M
粗利益率
37.1%
営業利益率
-92.3%
純利益率
-90.4%
前年比成長
13.8%
EPS
$-0.11
資金フロー
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Q4 2025 財務サマリー
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported revenue of $44.6M (up 13.8% YoY) for Q4 2025, with a net profit of $-40.4M (down 1802.7% YoY) (-90.4% margin). Cost of goods sold was $28.1M, operating expenses totaled $57.8M.
主要財務指標
| 総売上高 | $44.6M |
|---|---|
| 純利益 | $-40.4M |
| 粗利益率 | 37.1% |
| 営業利益率 | -92.3% |
| 報告期間 | Q4 2025 |
売上内訳
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Q4 2025 revenue of $44.6M breaks down across 2 segments, led by Products at $39.0M (87.3% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Products | $39.0M | 87.3% |
| Service And Other | $5.7M | 12.7% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. セグメント別売上 — 四半期推移
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Service And Other) has evolved quarter over quarter.
| セグメント | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Products | $39.0M | $32.6M | $33.1M | $31.1M |
| Service And Other | $5.7M | $5.8M | $6.7M | $6.0M |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 年度売上推移
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $160.0M). Click any linked year to see what changed vs the prior 10-K.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 四半期売上・純利益の履歴
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $44.6M | +13.8% | $-40.4M | -90.4% |
| Q3 2025 | $38.4M | -3.8% | $-38.0M | -98.9% |
| Q2 2025 | $39.8M | +10.4% | $-41.9M | -105.4% |
| Q1 2025 | $37.2M | -4.3% | $-426.1M | -1146.8% |
| Q4 2024 | $39.2M | — | $2.4M | 6.0% |
| Q3 2024 | $40.0M | -28.2% | $-60.7M | -151.9% |
| Q2 2024 | $36.0M | -24.3% | $-173.3M | -481.3% |
| Q1 2024 | $38.8M | -0.2% | $-78.2M | -201.4% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $38.8M | $36.0M | $40.0M | $39.2M | $37.2M | $39.8M | $38.4M | $44.6M |
| 前年比成長 | -0.2% | -24.3% | -28.2% | N/A | -4.3% | 10.4% | -3.8% | 13.8% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $1.67B | $1.51B | $1.45B | $1.26B | $860.8M | $825.5M | $803.2M | $784.1M |
| 総負債 | $1.02B | $1.02B | $996.9M | $753.9M | $769.2M | $764.0M | $767.1M | $778.7M |
| 株主資本 | $649.0M | $492.7M | $453.1M | $506.6M | $91.6M | $61.5M | $36.1M | $5.3M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $-75.7M | $-54.3M | $-45.5M | $-30.6M | $-44.1M | $-29.4M | $-18.7M | $-19.1M |